Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
clinical trials
5
×
life sciences
5
×
national blog main
raleigh-durham blog main
5
×
raleigh-durham top stories
boston blog main
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer
immunotherapy
national
abeona therapeutics
accent therapeutics
achilles therapeutics
acute migrane
aimmune therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
What
drug
5
×
fda
approval
friday
market
migraine
new
patients
won
activity
acute
addresses
advantages
agency
aimmune
allergy
approved
awarded
bar
bio
biotech
brings
cancer
causes
companies
condition
days
decades
developed
dog
eisai
eli
expect
firm
flags
gamble
giant
giving
hasn’t
higher
Language
unset
5
×
Current search:
drug
×
biotech
×
unset
×
" life sciences "
×
" clinical trials "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
